Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians

Paolo Maggi, Giuseppe Vittorio De Socio, Stefania Cicalini, Maurizio D'Abbraccio, Gabriella Dettorre, Antonio Di Biagio, Canio Martinelli, Giuseppe Nunnari, Stefano Rusconi, Laura Sighinolfi, Vincenzo Spagnuolo, Nicola Squillace

Research output: Contribution to journalArticle

Abstract

We conducted a survey among Italian HIV specialists to study the utilization of statins and aspirin, administering a questionnaire aimed at investigating their use, the use of guidelines and scores, and the management of interactions. The answers were uniform in the different geographic areas. The majority directly prescribe statins and 43% of them prescribe aspirin. The majority follows guidelines and utilize scores to calculate the CV risk. Our survey demonstrates the commitment and autonomy in prescribing statins and aspirin of Italian physicians. There is a rationale to generate guidelines to overcome the differences and limitations among current recommendations.

Original languageEnglish
Pages (from-to)139-142
Number of pages4
JournalNew Microbiologica
Volume40
Issue number2
Publication statusPublished - Apr 1 2017

Keywords

  • Aspirin.
  • Cardiovascular disease
  • HIV
  • Statins

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians'. Together they form a unique fingerprint.

  • Cite this

    Maggi, P., De Socio, G. V., Cicalini, S., D'Abbraccio, M., Dettorre, G., Di Biagio, A., Martinelli, C., Nunnari, G., Rusconi, S., Sighinolfi, L., Spagnuolo, V., & Squillace, N. (2017). Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians. New Microbiologica, 40(2), 139-142.